CLEVELAND, Nov. 16, 2022 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced today it has released a new version of its AI auto-contouring solution, Contour ProtégéAI™ Version 1.1.3.
Version 1.1.3 adds refinements to the Contour ProtégéAI algorithm, which is used at hundreds of clinics nationwide. One of the advantages of deep learning algorithms is their ability to improve the overall results with additional information in a refined dataset.
"Our team has made a great effort to focus this new release on direct feedback from our customers," said Jay Obman, Product Manager at MIM Software. "The quality improvements were completely driven by the requests we've received, and as a result, our users can take advantage of even greater time savings."
Ad Statistics
Times Displayed: 9690
Times Visited: 30 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
Contour ProtégéAI seamlessly integrates into any department's workflow and can be rapidly implemented into virtually any environment via local deployment. User feedback and a determination to continuously improve AI auto-contouring were key drivers in developing the product.
About MIM Software Inc.
MIM Software Inc. is a privately held company with a dynamic working environment. It is headquartered in Cleveland, OH, with international offices in Beijing, Chengdu, and Brussels.
MIM Software sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies. The company's products are used in over 3,500 centers worldwide.
MIM Software Inc. is committed to enhancing patient care by providing customer-centered and innovative imaging solutions in the fields of Radiology, Nuclear Medicine, Neuroimaging, Cardiac Imaging, and Radiation Oncology.
SOURCE MIM Software Inc.
